Background Resistance to erythropoiesis-stimulating agents (ESA) is associated with
adverse outcomes in patients undergoing chronic hemodialysis. However, the impact of …

Background Obesity is associated with type 2 diabetes mellitus and chronic low-grade
inflammation. Although chronic inflammatory conditions and diabetes are associated with …

During human pregnancy, iron requirements gradually increase, leading to higher amounts
of erythropoietin (EPO) and reticulocytes, and changes in erythrocyte size and density …

Objective This study aimed to determine if adapted Global Leadership Initiative on
Malnutrition (GLIM) criteria can diagnose overnutrition, in addition to undernutrition, in …

Each patient undergoing maintenance haemodialysis (MHD) has a different response to
erythropoiesis-stimulating agents (ESAs). Haemodilution due to fluid overload has been …

Ischemic stroke is the most common stroke, caused by occlusion of cerebral vessels and
leading causes of disability. Erythropoietin (EPO) has non-hematopoietic effects as a …

Aim This study aims to determine if metabolic‐dysfunction‐associated fatty liver disease
(MAFLD) or advanced liver fibrosis is associated with erythropoietin stimulating agent (ESA) …

Background/Objectives: Besides a multitude of consequences patients on chronic renal
replacement therapy have, anemia is one of the most prominent factors making a significant …

Background Our aim was to elucidate whether Hb variability affects nutritional status in HD
patients. Methods This study included chronic HD patients (n= 76) with available monthly Hb …

The objective of this study was to understand the utilization pattern of erythropoietin in end-
stage renal disease patients, along with the effect of body weight and sex on the patients' …